Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients

BACKGROUND: Lipoprotein apheresis (LA) is considered as an add-on therapy for patients with familial hypercholesterolemia (FH). We aimed to analyze the data collected in the last 15 years from FH patients treated with LA, to elucidate the benefit of this procedure with respect to plasma lipids, biom...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Orphanet J Rare Dis
Huvudupphovsmän: Víšek, J., Bláha, M., Bláha, V., Lášticová, M., Lánska, M., Andrýs, C., Tebbens, J. Duintjer, Igreja e Sá, Ivone Cristina, Tripská, K., Vicen, M., Najmanová, I., Nachtigal, P.
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2021
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7913462/
https://ncbi.nlm.nih.gov/pubmed/33640001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-021-01749-w
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk